… whether the use of respiratory fluoroquinolones was associated with … fluoroquinolones (levofloxacin,
moxifloxacin, gemifloxacin) with macrolides or β-lactams or both. A meta-analysis …

… In conclusion, despite the limitations of our meta-analysis, we conclude that respiratory
fluoroquinolone monotherapy has similar efficacy and favorable safety compared with β-lactam …

… Fluoroquinolone antibiotics have a wide spectrum of … respiratory tract infections, urinary
tract infections, skin and soft tissue infections [1]. Nevertheless, several fluoroquinolones have …

… In the current review, the question was addressed of whether the use of a respiratory
fluoroquinolone alone or a macrolide alone, both providing adequate antimicrobial coverage …

Background Fluoroquinolones (FQs) are second-line antimicrobial agents. Once the decision
to prescribe an antimicrobial is made, the choice of antimicrobial should be based on both …

… trials or meta-analyses.9 , 10 We aimed to comprehensively reassess the role of … meta-analysis
The primary comparison in this meta-analysis involved respiratory fluoroquinolones …

… The Infectious Diseases Society of America and the American Thoracic Society (IDSA/ATS)
have recommended the use of respiratory fluoroquinolones for the treatment of adult …

… Our meta-analysis revealed a significant difference in clinical cure and microbiological
eradication rates between patients who received respiratory fluoroquinolone and β-lactam plus …

… were identified in this meta-analysis. The results of this meta-analysis indicated that
ceftriaxone combination therapy was similar to respiratory fluoroquinolone monotherapy, and the …

… , a fluoroquinolone with potent activity against respiratory … lower respiratory tract infections.
In this review, we critically examine its safety profile in comparison with other fluoroquinolones …